A major new Nature Medicine study found that nearly half of cancer patients experienced significant weight-loss episodes linked to cachexia. Learn what cancer cachexia is, why it can begin early, and what the new findings mean for patients and caregivers.

Depression during cancer treatment may affect more than quality of life. New research links depression with poorer cancer outcomes and highlights why mental health support should be part of supportive cancer care.

HuMOLYTE presented its latest research on chemotherapy-related mucositis at the 2026 Microbiome Forum in San Diego. Watch Dr. Sourabh Kharait’s presentation and explore our poster featuring preclinical findings and encouraging results from an initial 32-patient study.

October shines a light on breast cancer, metastatic breast cancer, and liver cancer. For patients and caregivers, it’s a time to focus on early detection, support, and advocacy.

Cancer treatment is about more than shrinking a tumor. Supportive care helps patients manage pain, nausea, diarrhea, dehydration, mouth sores, nutrition problems, fatigue, frailty, and other side effects that can make treatment harder to tolerate.

The WHO oral mucositis grading scale classifies mouth sores from Grade 0 to Grade 4 based on redness, ulceration, and the ability to eat and drink. Learn what each grade means, how the scale is used during cancer treatment, and how it compares with OMAS and CTCAE.

One family turned to HuMOLYTE during two difficult health journeys: chemotherapy for stage 4 lymphoma and recovery after prostate surgery. Hear their experience with hydration, gut health, and treatment support.

Chemotherapy can damage the protective lining of the mouth and gastrointestinal tract, contributing to mucositis, diarrhea, dehydration, and electrolyte loss. A peer-reviewed 2026 study investigated whether HuMOLYTE—a medical food containing 2′-fucosyllactose (2′-FL), magnesium, and electrolytes—could help support the mucosal barrier during chemotherapy. Here’s what researchers found in preclinical animal and laboratory models.

Cancer drug shortages are affecting major cancer centers across the U.S., including shortages of ifosfamide, carboplatin, and cisplatin. Learn why these shortages happen, how they can disrupt treatment, and what patients should ask their oncology team.

HuMOLYTE founder Dr. Sourabh Kharait will present the company’s preclinical and early clinical research on chemotherapy-induced mucositis at Microbiome 2026, highlighting the potential role of 2′-FL HMO, mucosal barrier support, and gut health during cancer treatment.

New preclinical research from MD Anderson suggests psilocybin may help prevent chemotherapy-induced peripheral neuropathy by protecting nerve cells. Here’s what the study found, how it may work, and why human trials are still needed.

The Oral Mucositis Assessment Scale (OMAS) gives researchers an objective way to measure mouth sores caused by chemotherapy and radiation therapy. Learn how OMAS scores redness and ulceration, how it differs from WHO mucositis grades, and why standardized assessment matters in cancer research.

September is one of the most powerful months for cancer awareness, honoring childhood, ovarian, prostate, thyroid, blood, and gynecologic cancers. Each ribbon tells a story, each campaign sparks conversation, and together they create a movement for education, early detection, and support.

Peripheral neuropathy is often blamed on chemotherapy, but new research suggests colorectal cancer itself may begin affecting peripheral nerves before treatment starts. A recent Nature Communications study found evidence of inflammation, myelin damage, altered lipid metabolism, and nerve dysfunction in mouse and primate models of colorectal cancer.

Chemotherapy can be physically and emotionally draining, making mental health just as important as physical recovery. From mindfulness techniques and support networks to nutrition and gentle exercise, there are ways to manage stress and enhance well-being. In this guide, we explore 10 practical coping strategies to help navigate the emotional challenges of cancer treatment with resilience and strength.

Chemo mouth is a common yet painful side effect of chemotherapy that can lead to dry mouth, sores, taste changes, and difficulty eating. Maintaining hydration and electrolyte balance is key to managing these symptoms. HuMOLYTE, an advanced electrolyte solution, supports both oral and gut health by replenishing essential electrolytes and protecting the mucosal lining. Learn how HuMOLYTE can help prevent chemo mouth and improve your overall well-being during cancer treatment.

Caring for someone with cancer can be deeply meaningful and deeply exhausting. Recognizing caregiver burnout early, sharing responsibilities, using respite care, and asking the cancer care team for support can help protect your health and make caregiving more sustainable.

New research suggests that Fusobacterium bacteria found inside some colorectal tumors may be linked to a higher risk of cancer recurrence and differences in chemotherapy benefit. Here’s what the study found—and what it means for patients.

Dr. Sourabh Kharait shares the unexpected startup journey behind HuMOLYTE, from a magnesium hydration product to a science-backed medical food for chemotherapy patients. His MedStart talk offers practical lessons on pivots, customer discovery, clinical research, funding, and finding product-market fit in life sciences.

Join Sacramento-area founders and entrepreneurs for Startup Happy Hour in Elk Grove featuring Rich Foreman, COO of IGH Naturals. This informal AMA-style event is a chance to hear candid startup lessons, ask questions, and connect with others building businesses in the region.